Search Page
Save citations to file
Email citations
Send citations to clipboard
Add to Collections
Add to My Bibliography
Create a file for external citation management software
Your saved search
Your RSS Feed
Filters
Results by year
Table representation of search results timeline featuring number of search results per year.
Year | Number of Results |
---|---|
2009 | 1 |
2010 | 1 |
2011 | 2 |
2013 | 1 |
2015 | 1 |
2024 | 0 |
Search Results
6 results
Results by year
Filters applied: . Clear all
It looks like you are searching for an author.
Results are currently sorted by Best Match. To see the newest results first,
change the sort order to Most Recent.
Page 1
PAX2 Expression in Ovarian Cancer.
Int J Mol Sci. 2013 Mar 15;14(3):6090-105. doi: 10.3390/ijms14036090.
Int J Mol Sci. 2013.
PMID: 23502471
Free PMC article.
Nutlin-3a: A Potential Therapeutic Opportunity for TP53 Wild-Type Ovarian Carcinomas.
Crane EK, Kwan SY, Izaguirre DI, Tsang YT, Mullany LK, Zu Z, Richards JS, Gershenson DM, Wong KK.
Crane EK, et al. Among authors: zu z.
PLoS One. 2015 Aug 6;10(8):e0135101. doi: 10.1371/journal.pone.0135101. eCollection 2015.
PLoS One. 2015.
PMID: 26248031
Free PMC article.
Item in Clipboard
BRAF mutation is rare in advanced-stage low-grade ovarian serous carcinomas.
Wong KK, Tsang YT, Deavers MT, Mok SC, Zu Z, Sun C, Malpica A, Wolf JK, Lu KH, Gershenson DM.
Wong KK, et al. Among authors: zu z.
Am J Pathol. 2010 Oct;177(4):1611-7. doi: 10.2353/ajpath.2010.100212. Epub 2010 Aug 27.
Am J Pathol. 2010.
PMID: 20802181
Free PMC article.
Item in Clipboard
PAX2 expression in low malignant potential ovarian tumors and low-grade ovarian serous carcinomas.
Tung CS, Mok SC, Tsang YT, Zu Z, Song H, Liu J, Deavers MT, Malpica A, Wolf JK, Lu KH, Gershenson DM, Wong KK.
Tung CS, et al. Among authors: zu z.
Mod Pathol. 2009 Sep;22(9):1243-50. doi: 10.1038/modpathol.2009.92. Epub 2009 Jun 12.
Mod Pathol. 2009.
PMID: 19525924
Free PMC article.
Item in Clipboard
The anterior gradient homolog 3 (AGR3) gene is associated with differentiation and survival in ovarian cancer.
King ER, Tung CS, Tsang YT, Zu Z, Lok GT, Deavers MT, Malpica A, Wolf JK, Lu KH, Birrer MJ, Mok SC, Gershenson DM, Wong KK.
King ER, et al. Among authors: zu z.
Am J Surg Pathol. 2011 Jun;35(6):904-12. doi: 10.1097/PAS.0b013e318212ae22.
Am J Surg Pathol. 2011.
PMID: 21451362
Free PMC article.
Item in Clipboard
The insulin-like growth factor 1 pathway is a potential therapeutic target for low-grade serous ovarian carcinoma.
King ER, Zu Z, Tsang YT, Deavers MT, Malpica A, Mok SC, Gershenson DM, Wong KK.
King ER, et al. Among authors: zu z.
Gynecol Oncol. 2011 Oct;123(1):13-8. doi: 10.1016/j.ygyno.2011.06.016. Epub 2011 Jul 2.
Gynecol Oncol. 2011.
PMID: 21726895
Free PMC article.
Item in Clipboard
Cite
Cite